http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 23 Jul 2026 16:15:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Transcode+Therapeutics%2C++++++++++++++++Filed+by%3A+CK+Life+Sciences+Intl+%28Holdings%29+Inc/26808280.html si-local-file:///var/storage/secattach/20260723/26808280.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Transcode+Therapeutics%2C++++++++++++++++Filed+by%3A+CK+Life+Sciences+Intl+%28Holdings%29+Inc/26808280.html Thu, 23 Jul 2026 16:15:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Transcode+Therapeutics%2C++++++++++++++++Filed+by%3A+CK+Life+Sciences+Intl+%28Holdings%29+Inc/26808280.html si-local-file:///var/storage/secattach/20260723/26808280.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Transcode+Therapeutics%2C++++++++++++++++Filed+by%3A+CK+Life+Sciences+Intl+%28Holdings%29+Inc/26808280.html Thu, 23 Jul 2026 16:15:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Transcode+Therapeutics%2C++++++++++++++/26790394.html si-local-file:///var/storage/secattach/20260720/26790394.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Transcode+Therapeutics%2C++++++++++++++/26790394.html Mon, 20 Jul 2026 17:07:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Transcode+Therapeutics%2C++++++++++++++/26790394.html si-local-file:///var/storage/secattach/20260720/26790394.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Transcode+Therapeutics%2C++++++++++++++/26790394.html Mon, 20 Jul 2026 17:07:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Transcode+Therapeutics%2C++++++++++++++/26790379.html si-local-file:///var/storage/secattach/20260720/26790379.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Transcode+Therapeutics%2C++++++++++++++/26790379.html Mon, 20 Jul 2026 17:05:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Transcode+Therapeutics%2C++++++++++++++/26790379.html si-local-file:///var/storage/secattach/20260720/26790379.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Transcode+Therapeutics%2C++++++++++++++/26790379.html Mon, 20 Jul 2026 17:05:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+20/26789877.html si-local-file:///var/storage/secattach/20260720/26789877.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+20/26789877.html Mon, 20 Jul 2026 16:15:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+20/26789877.html si-local-file:///var/storage/secattach/20260720/26789877.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+20/26789877.html Mon, 20 Jul 2026 16:15:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Transcode+Therapeutics%2C++++++++++++++++Filed+by%3A+CK+Life+Sciences+Intl+%28Holdings%29+Inc/26784526.html si-local-file:///var/storage/secattach/20260717/26784526.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Transcode+Therapeutics%2C++++++++++++++++Filed+by%3A+CK+Life+Sciences+Intl+%28Holdings%29+Inc/26784526.html Fri, 17 Jul 2026 16:16:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Transcode+Therapeutics%2C++++++++++++++++Filed+by%3A+CK+Life+Sciences+Intl+%28Holdings%29+Inc/26784526.html si-local-file:///var/storage/secattach/20260717/26784526.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Transcode+Therapeutics%2C++++++++++++++++Filed+by%3A+CK+Life+Sciences+Intl+%28Holdings%29+Inc/26784526.html Fri, 17 Jul 2026 16:16:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Transcode+Therapeutics%2C++++++++++++++/26784410.html si-local-file:///var/storage/secattach/20260717/26784410.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Transcode+Therapeutics%2C++++++++++++++/26784410.html Fri, 17 Jul 2026 16:08:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Transcode+Therapeutics%2C++++++++++++++/26784410.html si-local-file:///var/storage/secattach/20260717/26784410.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Transcode+Therapeutics%2C++++++++++++++/26784410.html Fri, 17 Jul 2026 16:08:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+16/26784356.html si-local-file:///var/storage/secattach/20260717/26784356.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+16/26784356.html Fri, 17 Jul 2026 16:06:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+16/26784356.html si-local-file:///var/storage/secattach/20260717/26784356.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+16/26784356.html Fri, 17 Jul 2026 16:06:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+02/26727593.html si-local-file:///var/storage/secattach/20260702/26727593.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+02/26727593.html Thu, 02 Jul 2026 16:06:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+02/26727593.html si-local-file:///var/storage/secattach/20260702/26727593.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jul+02/26727593.html Thu, 02 Jul 2026 16:06:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jun+18/26663125.html si-local-file:///var/storage/secattach/20260618/26663125.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jun+18/26663125.html Thu, 18 Jun 2026 08:01:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jun+18/26663125.html si-local-file:///var/storage/secattach/20260618/26663125.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Transcode+Therapeutics%2C+++For%3A+Jun+18/26663125.html Thu, 18 Jun 2026 08:01:00 -0400 O.50607779 RNAZ http://www.streetinsider.com/Press+Releases/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html <div class="xn-content"> <p><i>Live Webcast to Highlight TTX-MC138 Phase 2a Trial, Three-Platform Pipeline, and Investment Thesis</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:RNAZ" idsrc="xmltag.org" >TransCode Therapeutics, Inc.</span> (NASDAQ: RNAZ), a clinical-stage oncology company advancing a three-platform pipeline in RNA therapeutics and immuno-oncology, today announced it will host its first live virtual R&amp;D Webcast on <chron>Thursday, June 18, 2026</chron>, at <chron>10:00 a.m. Eastern Time</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html Mon, 08 Jun 2026 08:04:00 -0400 A.35954321 O.20737027 O.50607779 RNAZ http://www.streetinsider.com/Press+Releases/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html <div class="xn-content"> <p><i>Live Webcast to Highlight TTX-MC138 Phase 2a Trial, Three-Platform Pipeline, and Investment Thesis</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:RNAZ" idsrc="xmltag.org" >TransCode Therapeutics, Inc.</span> (NASDAQ: RNAZ), a clinical-stage oncology company advancing a three-platform pipeline in RNA therapeutics and immuno-oncology, today announced it will host its first live virtual R&amp;D Webcast on <chron>Thursday, June 18, 2026</chron>, at <chron>10:00 a.m. Eastern Time</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html Mon, 08 Jun 2026 08:04:00 -0400 A.35954321 O.20737027 O.50607779 RNAZ http://www.streetinsider.com/Press+Releases/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html <div class="xn-content"> <p><i>Live Webcast to Highlight TTX-MC138 Phase 2a Trial, Three-Platform Pipeline, and Investment Thesis</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:RNAZ" idsrc="xmltag.org" >TransCode Therapeutics, Inc.</span> (NASDAQ: RNAZ), a clinical-stage oncology company advancing a three-platform pipeline in RNA therapeutics and immuno-oncology, today announced it will host its first live virtual R&amp;D Webcast on <chron>Thursday, June 18, 2026</chron>, at <chron>10:00 a.m. Eastern Time</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html Mon, 08 Jun 2026 08:04:00 -0400 A.35954321 O.20737027 O.50607779 RNAZ http://www.streetinsider.com/Press+Releases/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html <div class="xn-content"> <p><i>Live Webcast to Highlight TTX-MC138 Phase 2a Trial, Three-Platform Pipeline, and Investment Thesis</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:RNAZ" idsrc="xmltag.org" >TransCode Therapeutics, Inc.</span> (NASDAQ: RNAZ), a clinical-stage oncology company advancing a three-platform pipeline in RNA therapeutics and immuno-oncology, today announced it will host its first live virtual R&amp;D Webcast on <chron>Thursday, June 18, 2026</chron>, at <chron>10:00 a.m. Eastern Time</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html Mon, 08 Jun 2026 08:04:00 -0400 A.35954321 O.20737027 O.50607779 RNAZ http://www.streetinsider.com/PRNewswire/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html <div class="xn-content"> <p><i>Live Webcast to Highlight TTX-MC138 Phase 2a Trial, Three-Platform Pipeline, and Investment Thesis</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:RNAZ" idsrc="xmltag.org" >TransCode Therapeutics, Inc.</span> (NASDAQ: RNAZ), a clinical-stage oncology company advancing a three-platform pipeline in RNA therapeutics and immuno-oncology, today announced it will host its first live virtual R&amp;D Webcast on <chron>Thursday, June 18, 2026</chron>, at <chron>10:00 a.m. Eastern Time</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html Mon, 08 Jun 2026 08:04:00 -0400 A.35954321 O.20737027 O.50607779 RNAZ http://www.streetinsider.com/PRNewswire/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html <div class="xn-content"> <p><i>Live Webcast to Highlight TTX-MC138 Phase 2a Trial, Three-Platform Pipeline, and Investment Thesis</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:RNAZ" idsrc="xmltag.org" >TransCode Therapeutics, Inc.</span> (NASDAQ: RNAZ), a clinical-stage oncology company advancing a three-platform pipeline in RNA therapeutics and immuno-oncology, today announced it will host its first live virtual R&amp;D Webcast on <chron>Thursday, June 18, 2026</chron>, at <chron>10:00 a.m. Eastern Time</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html Mon, 08 Jun 2026 08:04:00 -0400 A.35954321 O.20737027 O.50607779 RNAZ http://www.streetinsider.com/PRNewswire/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html <div class="xn-content"> <p><i>Live Webcast to Highlight TTX-MC138 Phase 2a Trial, Three-Platform Pipeline, and Investment Thesis</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.boston" idsrc="xmltag.org" >BOSTON</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:RNAZ" idsrc="xmltag.org" >TransCode Therapeutics, Inc.</span> (NASDAQ: RNAZ), a clinical-stage oncology company advancing a three-platform pipeline in RNA therapeutics and immuno-oncology, today announced it will host its first live virtual R&amp;D Webcast on <chron>Thursday, June 18, 2026</chron>, at <chron>10:00 a.m. Eastern Time</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/TransCode+Therapeutics+to+Host+R%26amp%3BD+Webcast+on+June+18%2C+2026/26614624.html Mon, 08 Jun 2026 08:04:00 -0400 A.35954321 O.20737027 O.50607779 RNAZ